Choreo LLC Reduces Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Choreo LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 12,374 shares of the medical equipment provider’s stock after selling 1,054 shares during the quarter. Choreo LLC’s holdings in Intuitive Surgical were worth $6,510,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Massachusetts Financial Services Co. MA acquired a new position in shares of Intuitive Surgical in the third quarter valued at approximately $558,807,000. International Assets Investment Management LLC grew its stake in Intuitive Surgical by 49,383.6% in the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after acquiring an additional 1,088,415 shares during the period. FMR LLC lifted its stake in shares of Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the period. Wilmington Savings Fund Society FSB boosted its holdings in shares of Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after purchasing an additional 552,058 shares during the last quarter. Finally, State Street Corp grew its position in shares of Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on ISRG shares. Wells Fargo & Company increased their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Bernstein Bank increased their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. Royal Bank of Canada boosted their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. BTIG Research increased their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Finally, Raymond James boosted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Stock Up 1.9 %

NASDAQ ISRG opened at $590.90 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The business has a 50 day moving average price of $551.99 and a two-hundred day moving average price of $512.04. The stock has a market cap of $210.47 billion, a PE ratio of 92.18, a P/E/G ratio of 5.51 and a beta of 1.39.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 28,843 shares of company stock valued at $15,357,560. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.